Read this article:
TG Therapeutics Announces FDA Accelerated Approval of UKONIQ™ (umbralisib)
Zentalis Pharmaceuticals to Participate in Two Upcoming Investor Conferences
Read the rest here:
Zentalis Pharmaceuticals to Participate in Two Upcoming Investor Conferences
Tauriga Sciences Inc. Showcases its Virtual Booth as a Corporate Exhibitor at 2021 CTIC Capital Pre-J.P. Morgan Healthcare Investor Summit This…
Data from Vallon Pharmaceuticals’ ADAIR Selected for Symposia Presentation at the Virtual 2021 APSARD Annual Meeting
Sorrento Announces Positive Preliminary Results of Phase 1b Study of COVI-MSC™ for Treatment of ICU COVID-19 Patients
Evaxion Biotech Announces Filing of Registration Statement in the U.S. for Proposed Initial Public Offering of Securities
Eloxx Pharmaceuticals to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
Pfizer and BioNTech to Submit Emergency Use Authorization Request Today to the U.S. FDA for COVID-19 Vaccine
Gilead and Galapagos announce New Commercialization and Development Agreement for Jyseleca® (filgotinib)
Read more from the original source:
Gilead and Galapagos announce New Commercialization and Development Agreement for Jyseleca® (filgotinib)
Adamas to Present at Upcoming Piper Sandler Conference
Go here to read the rest:
Adamas to Present at Upcoming Piper Sandler Conference
Diabetes Freedom Reviews: Does George Reilly Program Book Really Work?
Equillium Announces Positive Interim Data of Itolizumab in the First-line Treatment of Acute Graft-Versus-Host Disease
Annexon Expands Classical Complement Platform into Neurodegenerative Diseases of the Brain with Initiation of Huntington’s Disease Clinical Program
Ascendis Pharma A/S Announces Third Quarter 2020 Financial Results and Business Update Conference Call on November 11
Bellerophon Provides Clinical Program Update and Reports Third Quarter 2020 Financial Results
Go here to read the rest:
Bellerophon Provides Clinical Program Update and Reports Third Quarter 2020 Financial Results
Teneobio Announces a Research Collaboration and License Agreement With ArsenalBio
BioVie Interview to Air on Bloomberg International on the RedChip Money Report
Telo Genomics Announces Warrant Exercise Agreement
See original here:
Telo Genomics Announces Warrant Exercise Agreement
Greenwich Biosciences, Inc., a Subsidiary of GW Pharmaceuticals plc, Launches unspoken symphony, a Breakthrough Innovation Created for the US Epilepsy…
Opiant Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
See the original post here:
Opiant Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)